BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3253105)

  • 1. Complement component 3 (C 3) and diabetes mellitus.
    Krantz S; Stelter F; Lober M; Rjasanowski I; Michaelis D; Buske B
    Exp Clin Endocrinol; 1988 Mar; 92(3):287-96. PubMed ID: 3253105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement component 3 (C3) genetics and diabetes mellitus.
    Krantz S; Stelter F; Lober M; Gromoll B
    Biomed Biochim Acta; 1990; 49(12):1237-41. PubMed ID: 2097995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of factor B (Bf) and C3 component of complement in type 1 (insulin-dependent) diabetes mellitus: BFQO allele observed in a diabetic child.
    Staneková D; Niks M; Buc M; Starsia Z; Michalková
    Folia Biol (Praha); 1993; 39(3):117-23. PubMed ID: 8157131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
    Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
    Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in diabetes mellitus.
    Bergamaschini L; Gardinali M; Poli M; Lorini R; Bosi E; Agostoni A
    J Clin Lab Immunol; 1991 Jul; 35(3):121-7. PubMed ID: 1688167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of subtypes of the BF system in type 1 (insulin-dependent) and type 2 (non-insulin dependent) diabetes mellitus.
    Ratzmann KP; Geserick G; Schimke E; Schröder H
    Exp Clin Endocrinol; 1988 Dec; 92(2):177-81. PubMed ID: 3243336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritability of diabetes mellitus in Ethiopian diabetics.
    Mengesha B; Abdulkadir J
    East Afr Med J; 1997 Jan; 74(1):37-40. PubMed ID: 9145576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus.
    Liberatore RR; Barbosa SF; Alkimin Md; Bellinati-Pires R; Florido MP; Isaac L; Kirschfink M; Grumach AS
    Pediatr Diabetes; 2005 Dec; 6(4):206-12. PubMed ID: 16390389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretor state and complement levels (C3 and C4) in insulin dependent diabetes mellitus.
    Blackwell CC; Weir DM; Patrick AW; Collier A; Clarke BF
    Diabetes Res; 1988 Nov; 9(3):117-9. PubMed ID: 3243044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA antigens with diabetes mellitus in an Iraqi population.
    Jabbar AA; Mezaal TJ; Dawood FH
    Dis Markers; 1989; 7(2):79-85. PubMed ID: 2731409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.
    Ruuska P; Ilonen J; Mustonen A; Tiilikainen A
    Clin Exp Immunol; 1984 Jul; 57(1):12-6. PubMed ID: 6235073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
    Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
    J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decrease in the serum level of the C3 complement component in noninsulin dependent diabetes of recent onset].
    Vialettes B; Lassmann V; Vague P
    Diabete Metab; 1983 Mar; 9(1):66-8. PubMed ID: 6602072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum immunoglobulins and various components of complement in patients with insulin-dependent diabetes mellitus].
    Pietruska Z; Kinalska I; Jabłońska E; Czaczkowska T
    Przegl Lek; 1989; 46(3):338-41. PubMed ID: 2772239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement (C3) receptor dependent monocyte recognition in uncompensated diabetes mellitus types I and II].
    Gómez Rodríguez F; Ruiz Alcantarilla P; Zamora Madaria E
    Rev Clin Esp; 1986 Sep; 179(4):167-71. PubMed ID: 3532232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.